analgesics, opioid

Preferred Label : analgesics, opioid;

MeSH definition : Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.;

MeSH synonym : opioid analgesics; Opioid Analgesic; Analgesic, Opioid;

MeSH hyponym : Partial Opioid Agonists; Full Opioid Agonists; Opioid Mixed Agonist-Antagonists; opioids; Agonists, Partial Opioid; Opioid Agonists, Partial; Opioid Partial Agonists; Agonists, Opioid Partial; Partial Agonists, Opioid; Agonists, Full Opioid; Opioid Agonists, Full; Opioid Full Agonists; Agonists, Opioid Full; Full Agonists, Opioid; Agonist-Antagonists, Opioid Mixed; Mixed Agonist-Antagonists, Opioid; Opioid Mixed Agonist Antagonists; Opioid;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000701;

UMLS CUI

C0002772;

ATC code(s)
- Opioids in combination with non-opioid analgesics [ATC Code]
- buprenorphine [ATC Code]
- butorphanol [ATC Code]
- dextromoramide [ATC Code]
- dezocine [ATC Code]
- fentanyl [ATC Code]
- meptazinol [ATC Code]
- nalbuphine [ATC Code]
- natural opium alkaloids [ATC Code]
- opioid anesthetics [ATC Code]
- opioids [ATC Code]
- opioids in combination with antispasmodics [ATC Code]
- other opioids [ATC Code]
- papaveretum [ATC Code]
- pentazocine [ATC Code]
- phenazocine [ATC Code]
- piritramide [ATC Code]
- tilidine [ATC Code]
- tramadol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Opioid analgesic adverse reaction (disorder) [SNOMED CT concept]
- Poisoning caused by opiate analgesic drug (disorder) [SNOMED CT concept]
False automatic mappings
- Other opioids [ICD-10 Sub-category (who)]
Indexing information
- 2-amino-N-(6-benzyl-1,2,3,4-tetrahydroquinolin-4-yl)-3-(4-hydroxy-2,6-dimethylphenyl)propanamide [MeSH Supplementary Concept]
- 3-((2R,6R,11R)-8-hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl)-N-phenylpropanamide [MeSH Supplementary Concept]
- 7-(1-hydroxy-1-methyl-3-(thien-3-yl)propyl)-6,14-ethanotetrahydrooripavine [MeSH Supplementary Concept]
- DEL-6 peptide [MeSH Supplementary Concept]
- deltorphin II N-(ureidoethyl)amide [MeSH Supplementary Concept]
- iodobenzoylnaltrexamide [MeSH Supplementary Concept]
- trans-4-(p-bromophenyl)-4-(dimethylamino)-1-(2-thiophen-2-yl-ethyl)-cyclohexanol [MeSH Supplementary Concept]
Record concept(s)
- Full Opioid Agonists [MeSH concept]
- Opioid Mixed Agonist-Antagonists [MeSH concept]
- Partial Opioid Agonists [MeSH concept]
- analgesics, opioid [MeSH concept]
- opioids [MeSH concept]
See also
- narcotics [MeSH Descriptor]
- opioid-related disorders [MeSH Descriptor]
See also (suggested by CISMeF)
- Opioid-Induced Constipation [MeSH Descriptor]
See also inter- (CISMeF)
- Morphine (substance) [SNOMED CT concept]
- Morphine, morphine derivatives and metabolites [ICD-11 Extension code]
- Opioids [Bloc CIM-11]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 18,19-dihydroetorphine [MeSH Supplementary Concept]
- Buprenorphine, Naloxone Drug Combination [MeSH Descriptor]
- Dsuvia [MeSH Supplementary Concept]
- O-demethyltramadol [MeSH Supplementary Concept]
- OREX-1019 [MeSH Supplementary Concept]
- Remifentanil [MeSH Descriptor]
- Tapentadol [MeSH Descriptor]
- acetaminophen, hydrocodone drug combination [MeSH Supplementary Concept]
- acrylfentanyl [MeSH Supplementary Concept]
- alfentanil [MeSH Descriptor]
- alphaprodine [MeSH Descriptor]
- beta-casomorphins [MeSH Supplementary Concept]
- brorphine [MeSH Supplementary Concept]
- buprenorphine [MeSH Descriptor]
- butorphanol [MeSH Descriptor]
- carfentanil [MeSH Supplementary Concept]
- codeine [MeSH Descriptor]
- crotonylfentanyl [MeSH Supplementary Concept]
- cyclopropylfentanyl [MeSH Supplementary Concept]
- deltorphin I, Ala(2)- [MeSH Supplementary Concept]
- dermorphin [MeSH Supplementary Concept]
- desomorphine [MeSH Supplementary Concept]
- dextromoramide [MeSH Descriptor]
- dextropropoxyphene [MeSH Descriptor]
- dezocine [MeSH Supplementary Concept]
- dihydrocodeine [MeSH Supplementary Concept]
- dihydromorphine [MeSH Descriptor]
- diphenoxylate [MeSH Descriptor]
- dynorphin (1-13) [MeSH Supplementary Concept]
- endomorphin 1 [MeSH Supplementary Concept]
- endomorphin 2 [MeSH Supplementary Concept]
- enkephalin, ala(2)-mephe(4)-gly(5)- [MeSH Descriptor]
- enkephalin, d-penicillamine (2,5)- [MeSH Descriptor]
- enkephalin-Met, Ala(2)- [MeSH Supplementary Concept]
- eseroline [MeSH Supplementary Concept]
- ethylketocyclazocine [MeSH Descriptor]
- ethylmorphine [MeSH Descriptor]
- etorphine [MeSH Descriptor]
- fentanyl [MeSH Descriptor]
- furanyl fentanyl [MeSH Supplementary Concept]
- heroin [MeSH Descriptor]
- hydrocodone [MeSH Descriptor]
- hydromorphone [MeSH Descriptor]
- kappa-opioid agonist JT09 [MeSH Supplementary Concept]
- ketobemidone [MeSH Supplementary Concept]
- levorphanol [MeSH Descriptor]
- lofentanil [MeSH Supplementary Concept]
- meperidine [MeSH Descriptor]
- meptazinol [MeSH Descriptor]
- methadone [MeSH Descriptor]
- methadyl acetate [MeSH Descriptor]
- morphine [MeSH Descriptor]
- nalbuphine [MeSH Descriptor]
- nocistatin [MeSH Supplementary Concept]
- normethadone [MeSH Supplementary Concept]
- opiate alkaloids [MeSH Descriptor]
- opium [MeSH Descriptor]
- oxycodone [MeSH Descriptor]
- oxymorphone [MeSH Descriptor]
- paracymethadol [MeSH Supplementary Concept]
- pentazocine [MeSH Descriptor]
- phenazocine [MeSH Descriptor]
- phenoperidine [MeSH Descriptor]
- pirinitramide [MeSH Descriptor]
- promedol [MeSH Descriptor]
- protopine [MeSH Supplementary Concept]
- sufentanil [MeSH Descriptor]
- tilidine [MeSH Descriptor]
- tramadol [MeSH Descriptor]
- tramadol, dexketoprofen drug combination [MeSH Supplementary Concept]
- tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- opioids [ATC Code]
Validated automatic mappings to BTNT
- opioids [ATC Code]
Validated automatic mappings to NTBT
- Opioid [ICD-11 Extension code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients